HALOZYME THERAPEUTICS, INC.

HALO

HALOZYME THERAPEUTICS, INC.

HALO

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-29Shares Purchased (TTM):0Shares Sold (TTM):203,299

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:114,516,546Shares Outstanding:118,144,000Institutional Ownership Pct.:96.93%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	163	310	134	420	62	176	116	154	188	165	118	274
Debt Securities Available For Sale Excluding Accru…	68	9	9	282	486	572	480	512	341	299	218	209
Inventory Net	137	155	176	186	182	165	142	131	159	169	128	129
Prepaid Expense And Other Assets Current	109	71	65	95	77	45	39	44	85	46	49	49
Assets Current	933	1,003	825	1,329	1,123	1,262	1,085	1,127	988	874	746	879
Prepaid Expense And Other Assets Noncurrent	55	51	54	56	56	56	81	80	52	17	18	18
Goodwill	582	582	580	417	417	417	417	417	417	417	417	417
Intangible Assets Net Excluding Goodwill	922	952	981	349	366	384	402	420	437	455	473	491
Deferred Income Tax Assets Net	-	-	0	0	20	5	4	0	0	1	4	13
Restricted Cash And Cash Equivalents Noncurrent	1	2	3	-	0	0	0	-	-	-	0	0
Assets	2,577	2,673	2,525	2,221	2,054	2,197	2,063	2,118	1,969	1,842	1,733	1,893
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	24	14	21	15	19	20	10	12	15	13	12	19
Accrued Liabilities Current	112	140	156	111	116	130	129	96	118	118	101	95
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	-	1
Long Term Debt Current	209	209	-	711	-	-	-	-	-	-	0	0
Liabilities Current	344	363	177	837	134	150	139	109	133	132	112	115
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	2
Long Term Debt Noncurrent	1,938	1,936	2,143	800	1,509	1,507	1,506	1,504	1,503	1,501	1,499	1,498
Other Liabilities Noncurrent	103	106	114	72	78	56	55	40	31	31	38	28
Deferred Income Tax Liabilities Net	49	48	43	8	-	-	0	12	14	-	-	-
Liabilities	2,434	2,453	2,477	1,717	1,721	1,714	1,700	1,665	1,680	1,664	1,649	1,643
Stockholders Equity
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	0	27	12	24	0	8	0	62	31	12	2	26
Accumulated Other Comprehensive Income Loss Net Of…	-8	-13	-18	-22	-28	-3	4	-7	-2	-1	-9	1
Retained Earnings Accumulated Deficit	151	205	55	502	361	478	360	398	261	167	91	222
Stockholders Equity	144	220	49	504	333	482	364	453	289	178	84	249
Liabilities And Stockholders Equity	2,577	2,673	2,525	2,221	2,054	2,197	2,063	2,118	1,969	1,842	1,733	1,893
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	114	119	118	118	118	123	123	127	127	127	127	132
Shares Outstanding	114	119	118	118	118	123	123	127	127	127	127	132

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.71%	19.64%	24.29%	-	-	-	-	-	-	-	-	-
2025	-5.57%	-12.07%	-1.92%	20.29%	21.28%	8.78%	7.85%	4.03%	4.56%	-20.90%	-15.73%	-20.33%
2024	7.47%	27.06%	36.45%	22.93%	9.68%	-5.18%	-3.10%	-7.14%	8.36%	7.55%	4.01%	13.77%
2023	-	-	-	-1.13%	-11.80%	-22.93%	12.56%	4.82%	-2.98%	13.50%	7.25%	19.86%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.71	2.76	4.66	1.59	8.36	8.39	7.80	10.36	7.41	6.64	6.64	7.63
Quick Ratio	1.99	2.14	3.30	1.25	6.44	7.00	6.50	8.75	5.58	5.01	5.07	6.08
Working Capital	588.59M	639.83M	648.12M	491.52M	988.39M	1.11B	946.24M	1.02B	854.44M	741.95M	633.93M	763.82M
Leverage & Debt
Debt to Equity	16.96	11.17	50.73	3.41	5.17	3.55	4.67	3.68	5.80	9.36	19.68	6.60
Interest Coverage TTM	29.41	26.79	25.87	41.53	37.96	32.99	30.48	25.41	21.44	20.26	17.99	17.17
Debt Ratio	0.94	0.92	0.98	0.77	0.84	0.78	0.82	0.79	0.85	0.90	0.95	0.87
Efficiency & Turnover
Asset Turnover TTM	0.72	0.62	0.61	0.57	0.59	0.54	0.53	0.47	0.46	0.49	0.46	0.42
Per Share Metrics
Diluted EPS TTM	3.41	2.84	2.56	4.87	4.49	3.83	3.43	3.02	2.61	2.47	2.10	1.89
Free Cash Flow Per Share TTM	6.87	5.65	5.38	5.14	4.46	4.02	3.69	3.10	3.21	3.31	2.80	2.66
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	82.42%	82.79%	83.62%	84.55%	84.20%	83.45%	84.30%	82.09%	79.95%	78.50%	76.80%	76.66%
Operating Profit Margin TTM	35.90%	33.94%	33.58%	59.33%	57.92%	55.10%	54.32%	50.35%	46.04%	43.95%	40.71%	39.84%
Net Profit Margin TTM	24.86%	23.13%	22.69%	47.91%	47.28%	44.76%	43.74%	41.43%	38.62%	36.94%	33.96%	32.52%
Growth Metrics
Net Revenue Growth (1Y)	41.15%	39.12%	37.55%	31.19%	34.97%	25.65%	22.44%	21.35%	12.88%	22.41%	25.62%	34.46%
Net Income Growth (1Y)	-25.78%	-28.13%	-28.64%	51.73%	65.22%	52.25%	57.71%	54.57%	44.32%	75.52%	39.31%	20.22%
EPS Growth (1Y)	-23.21%	-25.04%	-24.48%	64.20%	73.08%	56.85%	64.05%	60.80%	49.56%	86.70%	44.51%	24.38%
Valuation Metrics
P/E TTM	22.19	21.89	25.45	14.44	11.33	16.20	13.65	18.50	19.73	16.20	17.32	19.85
P/B TTM	63.95	34.77	165.22	17.06	18.97	16.30	16.67	16.04	23.00	29.04	58.18	20.23
P/S TTM	5.52	5.06	5.77	6.92	5.36	7.25	5.97	7.66	7.62	5.98	5.88	6.46
Market Cap	9.18B	7.64B	8.07B	8.60B	6.31B	7.86B	6.06B	7.26B	6.66B	5.16B	4.88B	5.04B
Enterprise Value	11.16B	9.47B	10.07B	9.69B	7.76B	9.19B	7.45B	8.61B	7.97B	6.50B	6.26B	6.26B
Calculated Values
Free Cash Flow TTM	806.22M	667.65M	644.59M	602.40M	540.69M	495.76M	468.37M	392.71M	408.32M	420.33M	370.03M	350.38M
Net Debt	1.98B	1.83B	2.01B	1.09B	1.45B	1.33B	1.39B	1.35B	1.31B	1.34B	1.38B	1.22B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Krishnan, Mahesh

Title: -

Shares: 7,304

Price/Share: $75.00

Value: $547,800.00

Shares Owned: 14,462

Relationship: Director

Ownership: Direct

2026-06-03Sale

Owner: Torley, Helen

Title: PRESIDENT AND CEO

Shares: 10,000

Price/Share: $68.12

Value: $681,200.00

Shares Owned: 767,780

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Connaughton, Bernadette

Title: -

Shares: 1,625

Price/Share: $66.21

Value: $107,591.25

Shares Owned: 43,669

Relationship: Director

Ownership: Direct

2026-05-13Sale

Owner: Torley, Helen

Title: PRESIDENT AND CEO

Shares: 10,000

Price/Share: $69.40

Value: $694,000.00

Shares Owned: 767,780

Relationship: Director,Officer

Ownership: Direct

2026-05-01Sale

Owner: Connaughton, Bernadette

Title: -

Shares: 1,625

Price/Share: $63.48

Value: $103,155.00

Shares Owned: 38,498

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Krishnan, Mahesh	Director	-	Direct	Sale	7,304	75.00	$547,800.00	14,462	4
2026-06-03	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	68.12	$681,200.00	767,780	4
2026-06-01	Connaughton, Bernadette	Director	-	Direct	Sale	1,625	66.21	$107,591.25	43,669	4
2026-05-13	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	69.40	$694,000.00	767,780	4
2026-05-01	Connaughton, Bernadette	Director	-	Direct	Sale	1,625	63.48	$103,155.00	38,498	4
2026-04-06	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	63.58	$635,800.00	767,780	4
2026-04-02	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	64.47	$1,289,400.00	767,780	4
2026-03-10	Caudill, Cortney	Officer	SVP, CHIEF OPERATING OFFICER	Direct	Sale	8,857	67.64	$599,087.48	7,055	4
2026-03-04	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	70.44	$704,400.00	767,780	4
2026-02-05	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	78.66	$786,600.00	708,719	4
2026-01-05	Connaughton, Bernadette	Director	-	Direct	Sale	2,000	70.25	$140,500.00	40,123	4
2025-12-01	Connaughton, Bernadette	Director	-	Direct	Sale	829	71.60	$59,356.40	42,123	4
2025-12-01	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	16,569	69.98	$1,159,498.62	708,719	4
2025-11-12	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	70.99	$1,419,800.00	733,719	4
2025-11-10	Connaughton, Bernadette	Director	-	Direct	Sale	2,000	68.48	$136,960.00	42,952	4
2025-11-01	Caudill, Cortney	Officer	SVP, CHIEF OPERATING OFFICER	Direct	Sale	4,263	65.19	$277,904.97	12,737	4
2025-10-03	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	70.14	$1,402,800.00	733,719	4
2025-10-01	Connaughton, Bernadette	Director	-	Direct	Sale	2,000	75.40	$150,800.00	44,952	4
2025-09-22	Labrosse, Nicole	Officer	SVP, CHIEF FINANCIAL OFFICER	Direct	Sale	2,227	78.25	$174,262.75	22,079	4
2025-09-10	Labrosse, Nicole	Officer	SVP, CHIEF FINANCIAL OFFICER	Direct	Sale	20,000	75.61	$1,512,200.00	24,306	4
2025-09-04	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	74.36	$1,487,200.00	733,719	4
2025-09-02	Connaughton, Bernadette	Director	-	Direct	Sale	4,000	73.15	$292,600.00	46,952	4
2025-08-13	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	64.49	$1,289,800.00	733,719	4
2025-07-09	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	56.76	$1,135,200.00	733,719	4
2025-06-24	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	53.51	$1,070,200.00	733,719	4
2025-04-28	Henderson, Jeffrey Willia…	Director	-	Direct	Sale	4,497	60.67	$272,832.99	28,611	4
2025-04-01	Henderson, Jeffrey Willia…	Director	-	Direct	Sale	503	64.05	$32,217.15	33,108	4
2025-03-03	Henderson, Jeffrey Willia…	Director	-	Direct	Sale	5,000	58.52	$292,600.00	33,611	4
2025-02-27	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	1,697	58.50	$99,274.50	173,756	4
2025-02-03	Henderson, Jeffrey Willia…	Director	-	Direct	Sale	5,000	56.18	$280,900.00	38,611	4
2025-01-06	Henderson, Jeffrey Willia…	Director	-	Direct	Sale	10,000	50.01	$500,100.00	43,611	4
2024-10-16	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	53.26	$532,600.00	173,756	4
2024-10-09	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	53.02	$530,200.00	676,744	4
2024-09-26	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	56.10	$561,000.00	676,744	4
2024-09-18	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	62.24	$622,400.00	173,756	4
2024-09-12	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	59.20	$592,000.00	676,744	4
2024-08-21	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	62.04	$620,400.00	168,176	4
2024-08-15	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	57.95	$579,500.00	676,744	4
2024-08-14	Posard, Matthew L.	Director	-	Direct	Sale	9,881	57.70	$570,133.70	69,874	4
2024-07-24	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	55.12	$551,200.00	168,176	4
2024-07-22	Labrosse, Nicole	Officer	SVP, CHIEF FINANCIAL OFFICER	Direct	Sale	5,000	54.05	$270,250.00	15,480	4
2024-06-28	Labrosse, Nicole	Officer	SVP, CHIEF FINANCIAL OFFICER	Direct	Sale	10,000	52.04	$520,400.00	15,480	4
2024-06-18	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	49.43	$494,300.00	168,176	4
2024-06-12	Posard, Matthew L.	Director	-	Direct	Sale	10,000	50.62	$506,200.00	99,755	4
2024-05-22	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	45.38	$453,800.00	168,176	4
2024-04-17	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	38.49	$384,900.00	168,176	4
2024-03-13	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	42.27	$422,700.00	156,558	4
2024-02-28	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	39.55	$395,500.00	156,558	4
2024-01-17	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	36.00	$360,000.00	151,911	4
2023-12-13	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	40.39	$403,900.00	151,911	4
2023-11-15	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	39.79	$397,900.00	151,911	4
2023-10-17	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	36.52	$365,200.00	151,911	4
2023-09-19	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	39.10	$391,000.00	151,911	4
2023-08-31	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	42.82	$428,200.00	623,666	4
2023-08-22	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	42.41	$424,100.00	151,911	4
2023-08-17	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	43.18	$431,800.00	623,666	4
2023-08-14	Daly, James M	Director	-	Direct	Sale	10,000	43.74	$437,400.00	20,503	4
2023-07-27	Torley, Helen	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	43.79	$437,900.00	623,666	4
2023-07-18	Labarre, Michael J.	Officer	SVP, CHIEF TECHNICAL OFFICER	Direct	Sale	10,000	40.43	$404,300.00	141,911	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.93%

Inst. Shares: 114,516,546

Shares Outstanding: 118,144,000

2025-12-31

97.89%

Inst. Shares: 117,308,468

Shares Outstanding: 119,840,000

2025-09-30

97.22%

Inst. Shares: 113,965,349

Shares Outstanding: 117,219,000

2025-06-30

90.20%

Inst. Shares: 109,449,615

Shares Outstanding: 121,343,000

2025-03-31

92.56%

Inst. Shares: 114,045,216

Shares Outstanding: 123,215,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	114,516,546	118,144,000	96.93%
2025-12-31	117,308,468	119,840,000	97.89%
2025-09-30	113,965,349	117,219,000	97.22%
2025-06-30	109,449,615	121,343,000	90.20%
2025-03-31	114,045,216	123,215,000	92.56%
2024-12-31	115,767,692	126,827,000	91.28%
2024-09-30	115,119,339	126,850,000	90.75%
2024-06-30	113,321,264	127,116,000	89.15%
2024-03-31	112,136,615	126,941,000	88.34%
2023-12-31	113,654,191	131,927,000	86.15%
2023-09-30	111,894,123	131,965,000	84.79%
2023-06-30	111,454,869	131,730,000	84.61%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

HALOZYME THERAPEUTICS, INC. (HALO) — SEC Financial Statements & Analysis

HALOZYME THERAPEUTICS, INC. (HALO) is a biological products, (no diagnostic substances) company, incorporated in DE. HALOZYME THERAPEUTICS, INC. trades on Nasdaq as: HALO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), HALOZYME THERAPEUTICS, INC. reported a 41.15% year-over-year revenue growth, a Gross Profit Margin of 82.42% (TTM), a Debt-to-Equity ratio of 16.96x, a Price-to-Sales (P/S) ratio of 5.52x (TTM), a Price-to-Book (P/B) ratio of 63.95x (TTM), at a market cap of $9.18B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 41.15%
Gross Profit Margin TTM: 82.42%
Debt To Equity: 16.96x
P/S TTM: 5.52x
P/B TTM: 63.95x
Market Cap: $9.18B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HALOZYME THERAPEUTICS, INC. in?

HALOZYME THERAPEUTICS, INC. (HALO) operates in the Biological Products, (No Diagnostic Substances) industry.

What is HALO's market cap?

HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $9.18B as of 2026-06-30.

What is HALO's P/E ratio?

HALOZYME THERAPEUTICS, INC. (HALO)'s trailing twelve month P/E ratio is 22.19x as of 2026-06-30.

What exchange does HALO trade on?

HALOZYME THERAPEUTICS, INC. (HALO) trades on the Nasdaq.

Where is HALOZYME THERAPEUTICS, INC. incorporated?

HALOZYME THERAPEUTICS, INC. is incorporated in DE.